Preparation and characterization of lornoxicam loaded solid lipid nanoparticles made from different lipids

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue SUPPL.4, 2013, Pages 438-442

  Palei, Narahari N ^a   Das, Malay K ^a  

^a DIBRUGARH UNIVERSITY   (India)

Author keywords

In vitro release; Lornoxicam; SLNs; Stabilizers

Indexed keywords

LORNOXICAM; POLYSORBATE 80; POLYVINYL ALCOHOL; SOLID LIPID NANOPARTICLE;

ARTICLE; DRUG RELEASE; DRUG STABILITY; LIPOPHILICITY; PARTITION COEFFICIENT; ZETA POTENTIAL;

EID: 84888374745     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applica-tions. Adv Drug Deliv Rev 2001; 47: 165-96.
2. Lim SJ, Kim CK. Formulation parameters determining the physiochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002; 243: 135-46.
3. Kim BD, Na K, Choi HK. Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur J Pharm Sci 2005; 24: 199-205.
4. Balfour JA, Fitton A, Barradell LB. Lornoxicam, A review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 1996; 51(4): 639-657.
5. Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW, Yang CZ. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Rel1999; 59: 299-307.
6. Meastrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm 2006; 312: 53-60.
7. Battaglia L, Trotta M, Gallarate M, Carlotti ME, Zara GP, Bargoni A. Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability. J Microencapsul 2007; 24: 672-684.
8. Liu D, Jiang S, Shen H, Qin S, Liu J, Zhang Q, Li R, Xu Q. Diclofenac sodium loaded solid lipid nanoparticles prepares by emulsion/solvent evaporation method. J Nanopart Res 2011; 13: 2375-2386.
9. Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Rel 2004; 95: 627-638.
10. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloid Surf B biointer 2005; 45: 167-173.
11. 3 full-factorial design. AAPS Pharm SciTech 2010; 11: 489-496.
12. Kyo YC, chung JF. Physicochemical properties of nevirapine loaded solid lipid nanoparticles and nano structured lipid carrier. Colloids sur B biointer 2011; 83: 299-306.
13. Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glycerides lipids on plasma pharmacokinetics. Int J Pharm 2007; 335: 167-175.
14. Ozyazici M, Gokçe EH, Ertan G. Release and diffusional modeling of metronidazole lipid matrices. Eur J Pharm Biopharm 2006; 63: 331-339.
15. Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv Drug Deliv Rev 2001; 47: 3-19.
16. Reddy LH, Murthy RS. Etoposide loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation. AAPS PharmSciTech 2005; 6: E158-E166.